Trial Profile
A multicenter, placebo controlled, randomized, double blind, subject initiated study of the safety and efficacy of the electrokinetic transdermal system (ETS) with acyclovir gel for the episodic treatment of herpes labialis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2008
Price :
$35
*
At a glance
- Drugs Aciclovir (Primary)
- Indications Herpes labialis
- Focus Therapeutic Use
- Sponsors Transport Pharmaceuticals
- 01 Feb 2008 Status change from in progress to completed as reported by clinicaltrials.gov.
- 27 Aug 2007 Status changed from recruiting to in progress.
- 12 Feb 2007 New trial record.